These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20652944)

  • 1. Biomarkers for the prediction of major adverse cardiovascular events in patients with acute coronary syndrome.
    Zeng Q; Sun XN; Ma LH; Chen L; Wang Y; Chen C; Ye ZY; Wu ZH; Li YZ; Xu Y
    Anat Rec (Hoboken); 2010 Sep; 293(9):1512-8. PubMed ID: 20652944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
    Tello-Montoliu A; Marín F; Roldán V; Mainar L; López MT; Sogorb F; Vicente V; Lip GY
    J Intern Med; 2007 Dec; 262(6):651-8. PubMed ID: 17986200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission.
    Weber M; Bazzino O; Navarro Estrada JL; Fuselli JJ; Botto F; Perez de Arenaza D; Möllmann H; Nef HN; Elsässer A; Hamm CW
    J Am Coll Cardiol; 2008 Mar; 51(12):1188-95. PubMed ID: 18355657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of elevations in serum choline and free F2)-isoprostane to predict 30-day cardiovascular outcomes in patients with acute coronary syndrome.
    LeLeiko RM; Vaccari CS; Sola S; Merchant N; Nagamia SH; Thoenes M; Khan BV
    Am J Cardiol; 2009 Sep; 104(5):638-43. PubMed ID: 19699337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.
    Narain VS; Gupta N; Sethi R; Puri A; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2008; 60(6):536-42. PubMed ID: 19276492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A preliminary report on the prognostic significance of preoperative brain natriuretic peptide and postoperative cardiac troponin in patients undergoing major vascular surgery.
    Bolliger D; Seeberger MD; Lurati Buse GA; Christen P; Rupinski B; Gürke L; Filipovic M
    Anesth Analg; 2009 Apr; 108(4):1069-75. PubMed ID: 19299763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome.
    Eggers KM; Lagerqvist B; Venge P; Wallentin L; Lindahl B
    J Am Coll Cardiol; 2009 Jul; 54(4):357-64. PubMed ID: 19608034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities.
    Ang DS; Kong CF; Kao MP; Struthers AD
    Am Heart J; 2009 Jul; 158(1):133-40. PubMed ID: 19540403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of N-terminal pro-B-type natriuretic peptide in patients with acute coronary syndromes.
    Coppola G; Corrado E; Mulè MC; Augugliaro S; Cucchiara A; Novo G; Amoroso G; Assennato P; Hoffmann E; Vitale F; Novo S
    Coron Artery Dis; 2009 May; 20(3):225-9. PubMed ID: 19387249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of potential outcome benefit from ACE inhibition after acute coronary syndrome: a biomarker approach using N-terminal proBNP.
    Squire I; Quinn P; Narayan H; Khan S; Dhillon O; Ng K; Kelly D; Davies J; Ng L
    Heart; 2010 Jun; 96(11):831-7. PubMed ID: 20478862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving long-term risk prediction in patients with acute chest pain: the Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers.
    Eggers KM; Kempf T; Venge P; Wallentin L; Wollert KC; Lindahl B
    Am Heart J; 2010 Jul; 160(1):88-94. PubMed ID: 20598977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging cardiac markers in coronary disease: role of brain natriuretic peptide and other biomarkers.
    Palazzuoli A; Iovine F; Gallotta M; Nuti R
    Minerva Cardioangiol; 2007 Aug; 55(4):491-6. PubMed ID: 17653025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an optimized multimarker strategy for early risk assessment of patients with acute coronary syndromes.
    Möckel M; Danne O; Müller R; Vollert JO; Müller C; Lueders C; Störk T; Frei U; Koenig W; Dietz R; Jaffe AS
    Clin Chim Acta; 2008 Jul; 393(2):103-9. PubMed ID: 18423399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and their association with clinical outcome, troponin T and C-reactive protein in patients with acute coronary syndromes.
    Postadzhiyan AS; Tzontcheva AV; Kehayov I; Finkov B
    Clin Biochem; 2008 Feb; 41(3):126-33. PubMed ID: 18061588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short- and long-term risk stratification in acute coronary syndromes: the added value of quantitative ST-segment depression and multiple biomarkers.
    Westerhout CM; Fu Y; Lauer MS; James S; Armstrong PW; Al-Hattab E; Califf RM; Simoons ML; Wallentin L; Boersma E;
    J Am Coll Cardiol; 2006 Sep; 48(5):939-47. PubMed ID: 16949483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired endogenous thrombolysis in acute coronary syndrome patients predicts cardiovascular death and nonfatal myocardial infarction.
    Saraf S; Christopoulos C; Salha IB; Stott DJ; Gorog DA
    J Am Coll Cardiol; 2010 May; 55(19):2107-15. PubMed ID: 20447533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
    Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Lp-PLA2 in acute coronary syndrome: association with major adverse cardiac events in a community-based cohort.
    Li N; Li S; Yu C; Gu S
    Postgrad Med; 2010 Jul; 122(4):200-5. PubMed ID: 20675983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated factor XII type A and B-type natriuretic peptide are complementary and incremental predictors of mortality in patients following admission with acute coronary syndrome.
    Pönitz V; Brügger-Andersen T; Pritchard D; Grundt H; Staines H; Nilsen DW;
    Blood Coagul Fibrinolysis; 2009 Dec; 20(8):652-60. PubMed ID: 19809305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of B-type natriuretic peptide in addition to troponin I, creatine kinase-MB, and myoglobin on the risk stratification of emergency department chest pain patients with potential acute coronary syndrome.
    Brown AM; Sease KL; Robey JL; Shofer FS; Hollander JE
    Ann Emerg Med; 2007 Feb; 49(2):153-63. PubMed ID: 17084941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.